Ftse Mib
34.660,38
-0,50%
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
NASDAQ
17.133,13
-0,23%
Bitcoin
69.305,28
0,00%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Transition Therapeutics - Ordinary Shares (TTHI) Transition Therapeutics - Ordinary Shares (TTHI) Notizie

TTHI

Transition Therapeutics - Ordinary Shares (TTHI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTHI
DataOraFonteTitoloSimboloCompagnia
11/10/201619:51Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
13/09/201623:16Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
13/09/201623:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
09/09/201620:04Edgar (US Regulatory)Report of Foreign Issuer (6-k)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201614:56Edgar (US Regulatory)(25-NSE)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
31/08/201607:00Business WireOPKO Health Completes Acquisition of Transition TherapeuticsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201614:52Business WireTransition Therapeutics Shareholders Approve Acquisition by OPKO HealthNASDAQ:TTHITransition Therapeutics - Ordinary Shares
26/08/201600:46PR Newswire (US)Transition Therapeutics Announces Special Shareholder Meeting Voting Results Including Shareholder Approval of the Plan of Ar...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
30/06/201608:00Business WireOPKO Health to Acquire Transition TherapeuticsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
03/06/201612:01PR Newswire (Canada)Transition Therapeutics Receives Notification From NASDAQNASDAQ:TTHITransition Therapeutics - Ordinary Shares
11/05/201622:01PR Newswire (Canada)Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
09/05/201622:01PR Newswire (Canada)Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:3...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
25/04/201622:01PR Newswire (Canada)Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701NASDAQ:TTHITransition Therapeutics - Ordinary Shares
18/04/201612:01PR Newswire (US)Transition Therapeutics Provides Update on Type 2 Diabetes Drug Candidate TT401NASDAQ:TTHITransition Therapeutics - Ordinary Shares
01/03/201622:30PR Newswire (Canada)Transition Therapeutics to Present at the 36th Annual Cowen Healthcare ConferenceNASDAQ:TTHITransition Therapeutics - Ordinary Shares
11/02/201623:26Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
09/02/201622:32PR Newswire (Canada)Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
05/02/201619:01PR Newswire (US)Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
01/02/201612:01PR Newswire (Canada)Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401NASDAQ:TTHITransition Therapeutics - Ordinary Shares
06/01/201612:01PR Newswire (Canada)Transition Therapeutics Announces Annual General Meeting Voting ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
19/11/201517:45PR Newswire (Canada)Transition Therapeutics to Host Investor Day November 23 in New YorkNASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/11/201522:01PR Newswire (US)Transition Therapeutics Announces First Quarter Fiscal 2016 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
02/11/201512:01PR Newswire (US)Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
29/10/201521:01PR Newswire (US)Transition Therapeutics Announces Agreement for Phase 2 Study of TT701 Drug CandidateNASDAQ:TTHITransition Therapeutics - Ordinary Shares
28/10/201511:01PR Newswire (US)Transition Therapeutics Announces Presentation of ELND005 Phase 2/3 Clinical Study Results at Clinical Trials in Alzheimer's ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
15/10/201512:01PR Newswire (US)Transition Therapeutics Announces Results of Data Analysis from ELND005 Phase 2/3 Clinical Study in Agitation and Aggression ...NASDAQ:TTHITransition Therapeutics - Ordinary Shares
15/09/201522:32Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NASDAQ:TTHITransition Therapeutics - Ordinary Shares
15/09/201522:01PR Newswire (Canada)Transition Therapeutics Announces Fiscal 2015 Financial ResultsNASDAQ:TTHITransition Therapeutics - Ordinary Shares
14/09/201512:01PR Newswire (Canada)Transition Therapeutics to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. ESTNASDAQ:TTHITransition Therapeutics - Ordinary Shares
10/08/201522:01PR Newswire (Canada)Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth ConferenceNASDAQ:TTHITransition Therapeutics - Ordinary Shares
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:TTHI

La tua Cronologia

LSE
BE45
Citi Fun 24
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network